<DOC>
	<DOCNO>NCT01154244</DOCNO>
	<brief_summary>The purpose study investigate clinical characteristic newly diagnose , drug naïve type 2 diabetic patient accord insulin secretion insulin resistance .</brief_summary>
	<brief_title>Insulin Resistance Primary Pathogenesis Newly Diagnosed , Drug naïve Type 2 Diabetes Patients Korea</brief_title>
	<detailed_description>Primary Objective : To investigate whether insulin resistance insulin deficiency primary pathogenesis type 2 diabetes mellitus Korea Secondary Objectives : To investigate proportion patient severe insulin deficiency diagnosis , To investigate proportion metabolic syndrome patient newly diagnose , drug-naïve type 2 diabetes mellitus , To investigate proportion obesity patient newly diagnose , drug-naïve type 2 diabetes mellitus</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Newly diagnose , drug naïve type 2 DM patient give inform consent , Diagnosis type 2 DM make accord ADA guideline 2009 Exclusion Criteria : Patients age 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>Insulin deficiency</keyword>
	<keyword>HOMA-IR</keyword>
	<keyword>Drug naive</keyword>
	<keyword>Diabetes mellitus , type II</keyword>
</DOC>